Treatment of calcium nephrolithiasis in the patient with hyperuricosuria

Journal of Nephrology

Volumn 27, Issue 6, 2014, Pages 601-605

  Arowojolu, Omotayo ^a   Goldfarb, David S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allopurinol; Calcium; Calculi, renal; Febuxostat; Kidney stones; Nephrolithiasis; Uric acid; Urolithiasis

Indexed keywords

ALLOPURINOL; FEBUXOSTAT; INDAPAMIDE; PROBENECID; URIC ACID; BIOLOGICAL MARKER; CALCIUM OXALATE; URICOSURIC AGENT;

CALCIUM METABOLISM; CALCIUM STONE; COMPUTER ASSISTED TOMOGRAPHY; CRYSTALLIZATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; HYPERURICOSURIA; INFRARED SPECTROSCOPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; ULTRAVIOLET SPECTROSCOPY; URIC ACID URINE LEVEL; X RAY POWDER DIFFRACTION; DRUG EFFECTS; KIDNEY; METABOLISM; NEPHROLITHIASIS; RISK FACTOR; URINE;

ALLOPURINOL; BIOMARKERS; CALCIUM OXALATE; FEBUXOSTAT; HUMANS; INDAPAMIDE; KIDNEY; NEPHROLITHIASIS; RISK FACTORS; TREATMENT OUTCOME; URIC ACID; URICOSURIC AGENTS;

EID: 84911997597     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0084-x     Document Type: Review

References (18)

1. Coe FL (1977) Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med 87(4):404–410
2. Grover PK, Marshall VR, Ryall RL (2003) Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol 10(3):271–278
3. Ettinger B, Tang A, Citron JT, Livermore B, Williams T (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315(22):1386–1389
4. Lonsdale K (1968) Epitaxy as a growth factor in urinary calculi and gallstones. Nature 217(5123):56–58
5. Coe FL, Lawton RL, Goldstein RB, Tembe V (1975) Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc Soc Exp Biol Med 149(4):926–929
6. Grover PK, Ryall RL, Marshall VR (1993) Dissolved urate promotes calcium oxalate crystallization: epitaxy is not the cause. Clin Sci (Lond) 85(3):303–307
7. Grover PK, Ryall RL, Marshall VR (1992) Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kidney Int 41(1):149–154
8. Grover PK, Ryall RL, Marshall VR (1990) Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis. Clin Sci (Lond) 79(1):9–15
9. Grover PK, Ryall RL (2005) Comment on epitaxial relationships between uric acid crystals and mineral surfaces: a factor in urinary stone formation. Langmuir 21(23):10898
10. Curhan GC, Taylor EN (2008) 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73(4):489–496
11. Ettinger B (1989) Does hyperuricosuria play a role in calcium oxalate lithiasis? J Urol 141(3 Pt 2):738–741
12. Borghi L, Meschi T, Guerra A, Novarini A (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(Suppl 6):S78–S86
13. George J, Carr E, Davies J, Belch JJ, Struthers A (2006) High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid. Circulation 114(23):2508–2516
14. Stoller ML, Meng MV, Abrahams HM, Kane JP (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171(5):1920–1924
15. Ferraro PM, Taylor EN, Eisner BH et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA 310(4):408–415
16. Joshi S, Peck AB, Khan SR (2013) Nadph oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid Med Cell Longev 2013:462361
17. Goldfarb DS, Macdonald PA, Gunawardhana L, Chefo S, McLean L. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Clin J Am Soc Nephrol 2013
18. Fink HA, Wilt TJ, Eidman KE et al (2013) Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an american college of physicians clinical guideline. Ann Intern Med 158(7):535–543